| 产品名称： | Avian reovirus |
|---|---|
| 商品货号： | TS213470 |
| Classification： | Reoviridae, Reovirus |
| Agent： | Avian reovirus |
| Strain： | 2177 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Commercially-reared chickens afflicted with inflammation of the hock joints |
| Product Format： | freeze-dried |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host： | Cytopathic effects (syncytium and giant cell formation) within 5 to 7 days |
| Recommended Host： | chicken embryo fibroblasts chicken embryo, yolk or embryo; chicken embryo fibroblasts |
| Growth Conditions： | Temperature: 37°C Incubation: 2-4 days |
| Cryopreservation： | Storage temperature: -20C for lyophilized; -70C for frozen |
| Name of Depositor： | Univ. Delaware, Akzo Pharmaceuticals |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Commercially-reared chickens afflicted with inflammation of the hock joints |
| References： | Rosenberger JK, et al. Reovirus strain 2177 and vaccine containing same. US Patent 5,525,342 dated Jun 11 1996 RosenbergerCharacterization of Reoviruses Associated with a runting Syndrome in Chickens.In: RosenbergerDisease Prevention and Control in Poultry Production, Aug. 31-Sep 2, 1983Sydney Australia1983. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Avian reovirus |
|---|---|
| 商品货号： | TS213470 |
| Classification： | Reoviridae, Reovirus |
| Agent： | Avian reovirus |
| Strain： | 2177 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Commercially-reared chickens afflicted with inflammation of the hock joints |
| Product Format： | freeze-dried |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host： | Cytopathic effects (syncytium and giant cell formation) within 5 to 7 days |
| Recommended Host： | chicken embryo fibroblasts chicken embryo, yolk or embryo; chicken embryo fibroblasts |
| Growth Conditions： | Temperature: 37°C Incubation: 2-4 days |
| Cryopreservation： | Storage temperature: -20C for lyophilized; -70C for frozen |
| Name of Depositor： | Univ. Delaware, Akzo Pharmaceuticals |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Commercially-reared chickens afflicted with inflammation of the hock joints |
| References： | Rosenberger JK, et al. Reovirus strain 2177 and vaccine containing same. US Patent 5,525,342 dated Jun 11 1996 RosenbergerCharacterization of Reoviruses Associated with a runting Syndrome in Chickens.In: RosenbergerDisease Prevention and Control in Poultry Production, Aug. 31-Sep 2, 1983Sydney Australia1983. |
